These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 17618565

  • 1. [Combinational effects of bcl-2 antisense oligodeoxynucleotide and Rituximab on proliferation and apoptosis of B-lymphoma Raji cells].
    Shen YM, Yang XC, Shi YZ, Xie XF, Tang J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Aug; 23(8):727-30. PubMed ID: 17618565
    [Abstract] [Full Text] [Related]

  • 2. [Effects of bcl-2 antisense oligodeoxynucleotide on proliferation and apoptosis of Raji cells].
    Wang FX, Dong ZR, Liu ZL, Zhang XJ, Yao L, Yang JC, Du XY.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):71-3. PubMed ID: 12697099
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R, Carbone R, Reiss M, Lacy J.
    Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
    [Abstract] [Full Text] [Related]

  • 4. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL, Hu WX, Lü YP, Qiu LN, Wang WS, Yang ZY, Liu JD, Rao GW.
    Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
    [Abstract] [Full Text] [Related]

  • 5. Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.
    Liu Y, Shen Y, Qin C, Shi Y, Rong G, Yu X.
    Oncol Rep; 2013 Jan; 29(1):244-52. PubMed ID: 23076380
    [Abstract] [Full Text] [Related]

  • 6. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
    Olejniczak SH, Hernandez-Ilizaliturri FJ, Clements JL, Czuczman MS.
    Clin Cancer Res; 2008 Mar 01; 14(5):1550-60. PubMed ID: 18316580
    [Abstract] [Full Text] [Related]

  • 7. [Combinational effects of K-ras and IGF-IR antisense oligodeoxynucleotide on proliferation and apoptosis of human pancreatic cancer Patu8988 cells].
    Shen YM, Yang XC, Zhang MH, Shen JK, Sun YH.
    Ai Zheng; 2008 May 01; 27(5):496-504. PubMed ID: 18479599
    [Abstract] [Full Text] [Related]

  • 8. Development of rituximab-resistant B-NHL clones: an in vitro model for studying tumor resistance to monoclonal antibody-mediated immunotherapy.
    Jazirehi AR, Bonavida B.
    Methods Mol Biol; 2011 May 01; 731():407-19. PubMed ID: 21516425
    [Abstract] [Full Text] [Related]

  • 9. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B.
    Cancer Res; 2005 Jan 01; 65(1):264-76. PubMed ID: 15665303
    [Abstract] [Full Text] [Related]

  • 10. Chemosensitization of breast carcinoma cells with the use of bcl-2 antisense oligodeoxynucleotide.
    Yang JH, Feng F, Qian H, Cheng H.
    Breast; 2004 Jun 01; 13(3):227-31. PubMed ID: 15177426
    [Abstract] [Full Text] [Related]

  • 11. [Apoptotic effect of bcl-XL antisense oligodeoxynucleotide mediated by lipofectin on cell strain CNE-2Z].
    He GR, Zhou KY, Cai KR, Liang T, He CW, Zhang YF.
    Ai Zheng; 2003 Jan 01; 22(1):11-5. PubMed ID: 12561428
    [Abstract] [Full Text] [Related]

  • 12. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB, Zhou JH, Zuo MX, You QD.
    Yao Xue Xue Bao; 2008 Aug 01; 43(8):811-8. PubMed ID: 18956773
    [Abstract] [Full Text] [Related]

  • 13. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M.
    Ann N Y Acad Sci; 2004 Dec 01; 1028():90-103. PubMed ID: 15650235
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
    Alas S, Emmanouilides C, Bonavida B.
    Clin Cancer Res; 2001 Mar 01; 7(3):709-23. PubMed ID: 11297268
    [Abstract] [Full Text] [Related]

  • 15. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
    He DM, Zhang H.
    Ai Zheng; 2006 Jan 01; 25(1):40-4. PubMed ID: 16405747
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line.
    Joyner DE, Albritton KH, Bastar JD, Randall RL.
    J Orthop Res; 2006 Mar 01; 24(3):474-80. PubMed ID: 16450387
    [Abstract] [Full Text] [Related]

  • 18. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase.
    Berg RW, Werner M, Ferguson PJ, Postenka C, Vincent M, Koropatnick DJ, Behrend E.
    J Pharmacol Exp Ther; 2001 Aug 01; 298(2):477-84. PubMed ID: 11454908
    [Abstract] [Full Text] [Related]

  • 19. Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.
    Bonavida B, Vega MI.
    Drug Resist Updat; 2005 Aug 01; 8(1-2):27-41. PubMed ID: 15939340
    [Abstract] [Full Text] [Related]

  • 20. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
    Cao W, Li XQ, Wang X, Fan HT, Zhang XN, Hou Y, Liu SB, Mei QB.
    Phytomedicine; 2010 Jul 01; 17(8-9):598-605. PubMed ID: 20092988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.